# Remediation of Impaired Self-Regulation in Patients With Mild TBI

> **NCT02260570** · EARLY_PHASE1 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 55 (actual)

## Conditions studied

- Mild Traumatic Brain Injury

## Interventions

- **DRUG:** Tolcapone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02260570
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02260570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02260570, "Remediation of Impaired Self-Regulation in Patients With Mild TBI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02260570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*